Stablepoint Partners LLC Raises Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

Stablepoint Partners LLC lifted its stake in IQVIA Holdings Inc. (NYSE:IQV) by 9.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,950 shares of the medical research company’s stock after buying an additional 500 shares during the period. Stablepoint Partners LLC’s holdings in IQVIA were worth $1,169,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of IQV. Private Trust Co. NA raised its position in IQVIA by 10.7% during the third quarter. Private Trust Co. NA now owns 485 shares of the medical research company’s stock worth $115,000 after acquiring an additional 47 shares during the last quarter. Clear Harbor Asset Management LLC raised its position in shares of IQVIA by 1.3% during the 3rd quarter. Clear Harbor Asset Management LLC now owns 3,969 shares of the medical research company’s stock worth $941,000 after purchasing an additional 50 shares during the last quarter. Pine Valley Investments Ltd Liability Co lifted its stake in IQVIA by 0.5% in the 3rd quarter. Pine Valley Investments Ltd Liability Co now owns 9,481 shares of the medical research company’s stock valued at $2,247,000 after buying an additional 50 shares in the last quarter. Fortitude Family Office LLC grew its holdings in IQVIA by 2.9% during the 3rd quarter. Fortitude Family Office LLC now owns 1,977 shares of the medical research company’s stock valued at $468,000 after buying an additional 56 shares during the last quarter. Finally, Huntington National Bank raised its holdings in shares of IQVIA by 7.4% in the third quarter. Huntington National Bank now owns 809 shares of the medical research company’s stock worth $192,000 after acquiring an additional 56 shares during the last quarter. 89.62% of the stock is currently owned by institutional investors and hedge funds.

IQVIA Stock Performance

NYSE:IQV opened at $204.54 on Monday. IQVIA Holdings Inc. has a twelve month low of $187.62 and a twelve month high of $261.73. The firm has a market capitalization of $37.12 billion, a price-to-earnings ratio of 26.84, a PEG ratio of 2.14 and a beta of 1.48. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76. The firm’s fifty day simple moving average is $199.71 and its 200 day simple moving average is $221.11.

Analysts Set New Price Targets

A number of research firms recently commented on IQV. TD Cowen dropped their price objective on IQVIA from $270.00 to $255.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Bank of America cut their price objective on shares of IQVIA from $255.00 to $235.00 and set a “buy” rating for the company in a research report on Friday, December 13th. Evercore ISI lowered their target price on shares of IQVIA from $270.00 to $265.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Robert W. Baird reduced their price target on IQVIA from $212.00 to $210.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 21st. Finally, The Goldman Sachs Group decreased their price objective on IQVIA from $280.00 to $250.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $255.71.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.